Publication:
Emerging role of sentinel lymph node mapping for gynecologic oncology in the new era

dc.contributor.authorTantitamit T.
dc.contributor.authorHuang K.-G.
dc.contributor.authorTemtanakitpaisan A.
dc.date.accessioned2021-04-05T03:02:17Z
dc.date.available2021-04-05T03:02:17Z
dc.date.issued2019
dc.date.issuedBE2562
dc.description.abstractThis study aims to update a review of the recent literature on sentinel lymph node biopsy (SLNB) in common gynecological cancer. Fifty-eight published English-language articles were obtained. Most of the well-designed studies were conducted in the patient with vulvar, endometrial, and cervical cancer, but SLNB data in ovarian cancer is limited. The result of diagnostic accuracy reported a satisfactory with a high detection rate, a high sensitivity, and an acceptable febrile neutropenia (FN) rate in all cancer types. The technique of SLNB in vulvar prefers combined radiocolloid and dye methods. The common technique in endometrial and cervical cancer is laparoscopic or robotic-assisted surgery with cervical indocyanine green (ICG) injection injection while laparotomy is the most frequently used in studies of ovarian cancer. This evidence supports that SLN mapping could replace the traditional lymphadenectomy in early-stage vulvar, endometrial, and cervical cancer. The result of feasibility and efficacy of this procedure in ovarian cancer is promising but more studies are required. © 2019 S.O.G. CANADA Inc.. All rights reserved.
dc.format.mimetypeapplication/pdf
dc.identifier.citationEuropean Journal of Gynaecological Oncology. Vol 40, No.6 (2019), p.905-914
dc.identifier.doi10.12892/ejgo4793.2019
dc.identifier.issn3922936
dc.identifier.other2-s2.0-85086252723
dc.identifier.urihttps://hdl.handle.net/20.500.14740/5026
dc.rights.holderScopus
dc.subject.otherIndocyanine green
dc.subject.otherTracer
dc.subject.otherAge
dc.subject.otherBody mass
dc.subject.otherCancer grading
dc.subject.otherCancer localization
dc.subject.otherCancer size
dc.subject.otherCancer staging
dc.subject.otherDiagnostic accuracy
dc.subject.otherEndometrium cancer
dc.subject.otherFebrile neutropenia
dc.subject.otherFemale
dc.subject.otherFemale genital tract cancer
dc.subject.otherHistology
dc.subject.otherHuman
dc.subject.otherHysteroscopy
dc.subject.otherInjection site
dc.subject.otherJob experience
dc.subject.otherLaparoscopic surgery
dc.subject.otherLaparoscopy
dc.subject.otherLaparotomy
dc.subject.otherLymph node dissection
dc.subject.otherMedical history
dc.subject.otherNeoadjuvant chemotherapy
dc.subject.otherOvary cancer
dc.subject.otherParaaortic lymph node
dc.subject.otherReliability
dc.subject.otherReview
dc.subject.otherRobot assisted surgery
dc.subject.otherSentinel lymph node biopsy
dc.subject.otherSerosa
dc.subject.otherSurgeon
dc.subject.otherTumor biopsy
dc.subject.otherTumor volume
dc.subject.otherUterine cervix
dc.subject.otherUterine cervix cancer
dc.subject.otherUterine cervix conization
dc.subject.otherUterine fundus
dc.subject.otherVulva cancer
dc.titleEmerging role of sentinel lymph node mapping for gynecologic oncology in the new era
dc.typeReview
dspace.entity.typePublication
swu.datasource.scopushttps://www.scopus.com/inward/record.uri?eid=2-s2.0-85086252723&doi=10.12892%2fejgo4793.2019&partnerID=40&md5=cabd0760483aa76966e198fdc4dd5567

Files